Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 258

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 258
---
     77,138,354 |   |

____________ Notes:- (i)Considering OmnigenicsAI interim financial statements as of December 31, 2024.

113 (ii)See footnote (2) under “ Adjustments to Unaudited Pro Forma Combined Statement of Financial Position as of December 31 , 2024” section. Assumes that net assets contributed by Initial Shareholders are the historical equity of APx according to its financial statements as of December 31, 2024. (iii)See footnote (1) under “ Adjustments to Unaudited Pro Forma Combined Statement of Financial Position as of December 31 , 2024” section. (iv)See footnote (3) under “ Adjustments to Unaudited Pro Forma Combined Statement of Financial Position as of December 31 , 2024” section. (v)See footnote (4) under “ Adjustments to Unaudited Pro Forma Combined Statement of Financial Position as of December 31 , 2024” section. As described in the table above, the share premium is determined, in each case, as the difference between the book value of the net assets contributed and the nominal value of the shares issued (considering par value of $0.0001 per share). 114

Comparative Per Share Data The following table sets forth the historical comparative share information for OmnigenicsAI and APx on a stand -alonebasis and pro forma combined per share information after giving effect to the Business Combination The pro forma combined share information below does not purport to represent what the actual results of operations or the earnings per share would have been had the companies been combined during the periods presented, nor to project the Combined Company’s results of operations or earnings per share for any future date or period. The pro forma combined shareholders’ equity per share information below does not purport to represent what the value of APx and OmnigenicsAI would have been had the companies been combined during the periods presented.

|                                                                                                      |     |     OmnigenicsAI 
     (Historical) |                |     |          APx 
 (Historical) |                |     | Combined Pro Forma |    |     |             |    |     |             |    |
| Scenario 1 –                                                                                         
 Assuming no                                                                                          
 redemptions                                                                                          |     |                  | Scenario 2 –   
 Assuming 50%   
 of redemptions |     |              | Scenario 3 –   
 Assuming 100%  
 of red